We previously found that PD-1/PD-L1 expression in primary stage II/III CRC tumors is associated with poor prognosis and correlates with the expression of TGF-β and forkhead box P3 (FOXP3) [10]. The gene discussed is FOXP3; the disease is colorectal carcinoma.